Alzheimer's Disease and Neuroinflammation: Exploring Cellular and Molecular Mechanisms

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and behavioral changes. It is the most common cause of dementia, primarily affecting the elderly population. The pathological hallmarks of Alzheimer’s disease include extracellular amyloid-beta plaques, intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein, neuroinflammation, and synaptic dysfunction. This review explores the cellular and molecular mediators involved in the progression of Alzheimer’s disease, highlighting the role of amyloid-beta accumulation, tau pathology, neuroinflammatory responses mediated by microglia and astrocytes, oxidative stress, and inflammatory mediators. A deeper understanding of these cellular and molecular mechanisms is crucial for developing targeted therapeutic strategies to slow or halt disease progression.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-24
DOI
https://doi.org/10.5281/zenodo.15727968
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alzheimer's Disease and Neuroinflammation: Exploring Cellular and Molecular Mechanisms

Zenodo (CERN European Organization for Nuclear Research)
Alzheimer's disease research and treatments
article

Alzheimer's Disease and Neuroinflammation: Exploring Cellular and Molecular Mechanisms

article en

Abstract

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and behavioral changes. It is the most common cause of dementia, primarily affecting the elderly population. The pathological hallmarks of Alzheimer’s disease include extracellular amyloid-beta plaques, intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein, neuroinflammation, and synaptic dysfunction. This review explores the cellular and molecular mediators involved in the progression of Alzheimer’s disease, highlighting the role of amyloid-beta accumulation, tau pathology, neuroinflammatory responses mediated by microglia and astrocytes, oxidative stress, and inflammatory mediators. A deeper understanding of these cellular and molecular mechanisms is crucial for developing targeted therapeutic strategies to slow or halt disease progression.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 43%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.